GENETIC SIGNATURES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.73 AUD | -.--% |
|
-.--% | +67.82% |
| May. 27 | Genetic Signatures Ceases Development of EasyScreen Essentials Respiratory Product for US Market; Shares Down 11% | MT |
| Apr. 30 | Genetic Signatures Appoints Interim CEO | MT |
Evolution of the average Target Price on Genetic Signatures Limited
Price target over the last 5 years
History of analyst recommendation changes
3d15952dfd3b0313f48d8a874c6b12.3Zz__5ANJjv_ynUNOq0yarKwPAQGt-G2OrurCNJBDE4.rsq8jc9ld3SmnhRFQsgEMPrWDWc08dOCF9raUb4iQ3vv0aaMoT5PCK2DAg~69f74bfd97cfeda05c94b91e35a46e66
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.73
AUD
Average target price
0.75
AUD
Spread / Average Target
+2.74%
High Price Target
0.75
AUD
Spread / Highest target
+2.74%
Low Price Target
0.75
AUD
Spread / Lowest Target
+2.74%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
- Stock Market
- Equities
- GSS Stock
- Consensus Genetic Signatures Limited
